REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,748.00
Bid: 1,747.50
Ask: 1,748.50
Change: 14.50 (0.84%)
Spread: 1.00 (0.057%)
Open: 1,736.00
High: 1,750.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: UK Shares Dragged Down By Commodity Weakness

Wed, 01st Jun 2016 16:07

LONDON (Alliance News) - UK stocks closed lower on Wednesday, starting June in the red, as commodity stocks fell and a weak trading update hit shares in building materials company Wolseley.

The FTSE 100 closed down 0.6%, or 38.86 points, to 6,191.93, and the FTSE 250 closed down 0.7%, or 123.26 points, at 17,061.47. The AIM All-Share closed down 0.3%, or 2.34 points, to 737.16. In mainland Europe, the CAC 40 in Paris closed down 0.7%, and the DAX in Frankfurt fell 0.6%.

Commodity stocks dragged on London's blue-chip index, with Antofagasta, down 4.0%, Rio Tinto, down 3.7%, and Glencore, down 1.7%, all among the biggest fallers, on lower iron ore prices and lacklustre Chinese manufacturing data.

"It's been an unhappy to start to June for equity markets with big slides across the board led by basic resource stocks and weakness in commodity prices, as concerns about the global economy reassert themselves once more," Michael Hewson, chief market analyst at CMC Markets UK, said.

The results of a survey by Markit and Caixin showed that manufacturing activity in China remained below a key threshold in May.

The manufacturing purchasing managers index fell to 49.2 in May from 49.4 the prior month, which was below the 49.3 expected by economists. A reading below 50 indicates a contraction.

"A slide below USD50 a ton in iron ore prices has helped pull mining stocks down heavily along with weak Chinese PMI data overnight," said CMC's Hewson.

The worries sparked by the weak Chinese data were partly offset by better-than-expected US manufacturing data.

The Institute for Supply Management said its purchasing managers index rose to 51.3 in May from 50.8 in April, with a reading above 50 indicating growth in the manufacturing sector. Economists had expected a reading of 50.6.

Analysts at Capital Economics said the increase in the ISM manufacturing index still leaves it at a level that has historically has been consistent with GDP growth of only 2%. But Capital Economics had feared that the ISM would drop back below the 50 mark. Coupled with the services side of the US economy "doing much better", Capital Economics said actual second-quarter GDP growth will be nearer 3%.

In the US at the London equities close, the Dow Jones Industrial Average was down 0.2%, the S&P 500 down 0.1%, and the Nasdaq Composite down 0.1%.

Also on Wednesday, the Organisation for Economic Co-operation & Development warned that a vote for the UK to leave the EU in a referendum scheduled for June 23 would have a "substantial" impact on the UK economy.

Fears that the UK could back Brexit have already "undermined" growth, according to the OECD, which said a vote to leave would hit growth across Europe and rest of the world and trigger turbulence in financial markets.

The pound fell after an ICM poll conducted on behalf of the Guardian newspaper, released before the London market close on Tuesday, showed voters split 52% to 48% in favour of Brexit.

The pound was trading at USD1.4404 at the London close, down from USD1.4553 at the close on Tuesday. The euro was trading at USD1.1172, up from USD1.1131 at Tuesday's close. Gold was trading at USD1,210.03, down from USD1,213.55 at the close on Tuesday.

Brent crude was trading at USD49.62 at the London close, down from USD50.60 at Tuesday's close, as traders await a meeting of OPEC officials in Vienna on Thursday.

Also in the FTSE 100, pharmaceutical companies were among the strongest climbers, with Shire up 2.2%, and GlaxoSmithKline up 0.2%. Mediclinic International, the private hospital group added 2.0%.

Unilever, the Anglo-Dutch consumer goods company, rose by 0.9%, after signing an agreement to sell its AdeS soy beverage business in Latin America for USD575 million. Coca-Cola Co and bottler Coca-Cola Femsa are buying the AdeS soy business.

"This sale is a step in reshaping our portfolio in Latin America to deliver sustainable growth for Unilever and enables us to sharpen our focus," Miguel Kozuszok, EVP Latin America Unilever, said.

The AdeS brand has a presence in Brazil, Mexico, Argentina, Uruguay, Paraguay, Bolivia, Chile, and Colombia.

Elsewhere, Tesco, up 1.1%, was also among the risers, after it posted the slowest sales decline out of the big four supermarkets in the 12 weeks ended May 22.

According to sales data published by Kantar Worldpanel, UK supermarket sales rose by 0.1% year-on-year, the same rate as in the preceding 12-week period. Kantar said this was a positive performance for the overall market, as food price deflation remains at 1.5%.

Tesco's sales fell by 1.0% in the period and its market share slipped to 28.3% from 28.6%. That was a sign of stability in comparison to the "historic declines" that the UK's biggest retailer has faced over the past two years, Kantar Director Edward Garner said.

J Sainsbury, down 4.3%, which until last month had been posting consistent periods of sales growth, saw its sales fall by 1.2% and its market share slip to 16.2% from 16.5%.

Garner said this was due to a decline in multi-pack sales, as the supermarket shifts its promotional emphasis from multi-pack deals to straightforward price cuts.

Sainsbury's was joined by Wolseley, a distributor of heating and plumbing products and a supplier of builders' products, in the list of heaviest fallers in the blue-chip index.

Wolseley slumped by 5.7% after the company said revenue growth has slowed since the end of April, following a third quarter performance dulled by weak European businesses.

In the weeks since the third quarter ended on April 30, Wolseley said, like-for-like revenue growth has been 1.0%, compared to 2.8% in the prior quarter.

The company pledged to further restructuring in the UK and Europe, meaning the total costs of doing so in the financial year ending in July will rise to GBP20.0 million from the GBP15.0 million previously expected.

The news comes less than a week after Wolseley abandoned plans to hire defence and aerospace group Cobham's chief financial officer, Simon Nicholls.

That decision was seen by Barclays, Wolseley's broker, as a move to avoid "possible reputational risk" after Cobham in April warned that trading profit in the first quarter was GBP15.0 million, well behind the GBP50.0 million made in the first quarter of 2015.

Following the market close Wednesday FTSE Russell confirmed the changes to come about thanks to the quarterly review of the FTSE indices. Pharmaceutical company Hikma Pharmaceuticals will move back to the FTSE 100, while satellite communications firm Inmarsat will be demoted to the FTSE 250.

On the economic front on Thursday, expect monetary base and foreign investment data for stocks and bonds in Japan at 0050 BST. UK PMI construction data are due at 0930 BST, followed by EU producer price index data at 1000 BST.

The European Central Bank is set to take centre stage at 1245 BST. The ECB is expected to remain in "wait and see mode" at its June meeting on Thursday as the Governing Council continues to assess the myriad policy interventions made in March. The ECB's policy decision will be followed by a press conference with ECB President Mario Draghi at 1330 BST.

Draghi is one of several central bankers set to capture the attention of markets on Thursday, with FOMC Member Powell speaking at 1335 BST and Bank of England Governor Mark Carney at 1400 BST.

In the US, ADP Employment Change data comes at 1315 BST, followed by jobless claims data at 1330 BST. EIA natural gas storage and crude oil stocks data come at 1530 BST and 1600 BST.

In the corporate calendar, Johnson Matthey publishes annual results on Thursday, with analysts widely viewing the 2016 financial year as an "off" period for the company, after which robust growth will resume thanks to increasingly stringent emissions regulations on motor vehicles.

The FTSE 100-listed platinum and chemicals company, which makes emission control systems, catalysts and fine chemicals, affirmed guidance for the financial year that ended in March in its third-quarter trading update in February.

But Johnson Matthey said macroeconomic factors, particularly the low oil price, the slowdown of economic growth in China and lower platinum prices, had continued to prove a challenge and were likely to remain an issue in the final quarter.

RPC Group also published full-year earnings.

By Samuel Agini; samagini@alliancenews.com; @SamuelAgini

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.